Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

IRVINE, Calif., June 28, 2018 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today commented on the anno... Devices, Interventional, Cardiology, Reimbursement Edwards Lifesciences, transcatheter, aortic valve, TAVR
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news